Subclinical ketosis (SCK) and periparturient diseases considerably account for 18 economic and welfare losses in dairy cows. The majority of scientific reports investigating the 19 prevalence of SCK and production diseases are based on empirical studies conducted in 20 Western Europe and North America. The present study surveyed the prevalence of SCK and 21 production-related clinical diseases in early lactating cows in various countries across the 22 world other than those in North America and Western Europe. Twelve countries of South and 23 Central America (Argentina, Brazil, Chile, Colombia, Mexico), Africa (South Africa), Asia 24 (Thailand, China), Eastern Europe (Russia, Ukraine), Australia and New Zealand were 25 assessed, and data from a total of 8,902 cows kept at 541 commercial dairy farms were 26 obtained. A minimum of 5 cows per farm were blood sampled and examined once after 27 parturition up to day 21 of lactation. Blood concentration of β-hydroxybutyrate (BHBA) was 28 measured (threshold for SCK: 1.2 mmol/l) and the presence of production-related diseases 29 such as milk fever, retained placenta, mastitis, metritis, displaced abomasum, claw disease 30 and clinical ketosis was recorded. More than 95% of all cows were examined in their second 31 week of lactation. Across all investigated countries, the SCK prevalence was 24.1%, ranging 32 from 8.3% up to 40.1%. The prevalence of production-related diseases detected during the 33 first 21 days of lactation was relatively low (< 5%). Calculated odds ratios did not indicate an 34 elevated risk for production diseases in cows with SCK. Despite differences in production 35 systems across countries and variation between individual farms within a region, the present 36 study data on SCK prevalence align with observations in Western European and North 37 American dairy herds. At the very early stage of sampling and clinical examination for 38 detection of SCK, it cannot be excluded that certain production diseases such as DA, 39 lameness and mastitis have developed later. 40 66 [18] estimated that a reduction of 1% in SCK incidence would amount to a saving of 584 67 USD per year. Recently, McArt et al. [14] calculated the average total costs of 68 hyperketonemia (blood BHBA concentrations ≥1.2 mmol/l) to be 289 USD per case 69 diagnosed. 70
Introduction
At the onset of lactation, dairy cows experience a marked metabolic load due to the 43 prevailing negative energy balance, which makes them susceptible towards infectious and 44 metabolic diseases [1, 2] . Increased concentrations of circulating ketone bodies, 45 predominantly β-hydroxybutyrate (BHBA), without the presence of clinical signs of ketosis 46 are considered as subclinical ketosis (SCK; [3] ). The blood BHBA thresholds for SCK 47 diagnosis in literature range between 1.2 and 1.4 mmol/l [4] [5] [6] [7] [8] . Although symptoms of clinical 48 ketosis such as reduced milk production, lethargy and loss of appetite are commonly observed 49 at higher concentrations of BHBA (>3.0 mmol/l), some cows, however, may be exposed to 50 high BHBA concentrations without showing any clinical signs, whereas others develop 51 ketosis characteristics already at lower BHBA levels [2, 9, 10] . 52 SCK affects performance and is obviously related to an increased risk of production- 53 related diseases such as clinical ketosis, displaced abomasum (DA), retained placenta, and 54 metritis [11, 12] . Concomitantly, production efficiency decreases (e.g. lower milk production, 55 poor fertility, and increased culling rates) which results in economic losses [11] [12] [13] [14] [15] . Serum 56 BHBA concentrations ≥1.2 mmol/l in the first week after calving were associated with a 57 several fold increased risk of subsequently developing DA and metritis, respectively [11] . 58 Ospina et al. [16] found increased risk ratios of 4.9 for clinical ketosis, 2.3 for metritis and 6.9 59 for DA when plasma BHBA concentrations exceeded a threshold of 1.0 mmol/l during days 3 60 to 14 post partum. A negative impact of SCK on milk yield of early lactating cows was 61 reported by several authors [10] [11] [12] 17 ]. Furthermore, cows with BHBA concentrations above 62 1.0 mmol/l in the first week after calving were significantly less likely to be diagnosed 63 pregnant after first insemination [13] . The economic impact of SCK is therefore indisputable, 64 although exact figures quantifying the actual costs of SCK are difficult to collect. Based on an 65 earlier investigation on Canadian dairy farms including more than 2,600 cows, McLaren et al. 91 The study was conducted from June 2011 to September 2013 at different commercial 92 dairy farms in 12 different countries worldwide ( 139 Blood BHBA concentrations observed between day 2 and day 21 p.p. were The overall prevalence of production diseases was 4.3% for milk fever, 4.0% for 170 retained placenta, 3.4% for mastitis, 1.7% for claw disease and 5.3% for metritis ( Management and environmental conditions are crucial factors that affect the ability of cows to 244 cope successfully with the imposed metabolic load. These circumstances cannot be effectively 245 recorded in a field study like the present one. Furthermore, one might speculate on regional 246 differences in terms of breed and feeding system affecting the development of health pasture, it appears to be less frequent and to be usually based on a different aetiology [27, 28] . 255 In contrast, we observed that mastitis prevalence in cows with SCK can be elevated 256 independent if cows were kept on pasture or indoors.
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Concentration of blood BHBA and subclinical ketosis
In conclusion, findings of the present study showed that SCK in dairy cows is a global 260 issue and can be observed at various rates in many countries over the world. Possibly due to 
